WASHINGTON (AP) — Medicare says it will cover breakthrough gene therapy for some kinds of blood cancers, increasing access to a potentially life-saving but costly treatment that uses a patient’s own cells to destroy malignancies. In a decision issued Wednesday, officials said Medicare will cover CAR-T cell therapies for certain types of lymphoma and leukemia. […]
This story is from The Seattle Times. Read the rest of this News story at https://www.seattletimes.com/seattle-news/health/medicare-to-cover-breakthrough-gene-therapy-for-some-cancers/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_seattle-news.